Dr. Kristina Bundra was born in Queens, New York and comes from a family with Macedonian and Serbian roots. She earned her Doctor of Pharmacy degree from MCPHS University in Boston, Massachusetts, where she graduated summa cum laude and was a distinguished member of the Rho Chi Society (Pharmaceutical Honor Society). She went on to complete a Post-Doctoral Pharmaceutical Industry Fellowship Program through Rutgers University. She has since spent most of her professional career in the pharmaceutical industry, working on scientific advances in the Oncology and Rare Disease landscape. She has held positions growing in leadership at Bristol-Myers Squibb, Bayer, and more recently Inhibrx. She has completed vast executive leadership training from Columbia University, NYU Stern, and Yale University.

Kristina has a longstanding history of being involved and has taken an active role with organizations serving individuals with unmet needs, from the National Organization for Rare Disorders, patient advocacy organizations, and more recently, the Novak Djokovic Foundation. She is very active in the Macedonian community and regularly participates in religious and cultural events in the New Jersey area. Being brought up in the cultural community, it has always been her belief that it is easier to know where you are going if you know where you are from. She believes in the value and importance of maintaining the integrity of her heritage, which has inspired her to take a more active role and give back. She is fluent in English, Macedonian, and Serbian. Kristina enjoys spending time with her family, traveling and exploring new places; and staying active with tennis and hiking.